Harnessing frontier cancer targets through exceptional drug discovery that is inspired by nature’s lessons


The mission of REVOLUTION Medicines is to discover and develop new drugs directed toward frontier oncology targets for cancer patients. The company draws inspiration from nature’s lessons including natural products that are inherently rich with biological function. REVOLUTION Medicines deploys an innovative toolkit including REVBLOCKS™, an integrated suite of modular synthesis methodologies applied to simple chemical “building blocks,” and the REVEAL™ computational platform, which uses evolution’s lessons to inform selection of chemical scaffolds and guide drug design for non-classical drug targets.


Year Invested: 2015
Location: Redwood City, Calif.
Visit: www.revolutionmedicines.com

Recent News

March 20, 2017
REVOLUTION Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development

December 20, 2016
REVOLUTION Medicines Raises Additional $25 Million in Series A Financing

December 13, 2016
REVOLUTION Medicines Names Distinguished Cancer Scientists and Drug Hunters to Senior Advisory Roles

Read More News

Associated Team Members

Mark A. Goldsmith, M.D., Ph.D.
Venture Partner

Alexis Borisy
Partner

Neil Exter
Partner